Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified (EGFRamp), recurrent glioblastoma (rGBM) Conference Paper uri icon

authors

  • van den Bent, Martin
  • Gan, Hui
  • Lassman, Andrew
  • Kumthekar, Priya
  • Merrell, Ryan
  • Butowski, Nicholas
  • Lwin, Zarnie
  • Mikkelsen, Tom
  • Nabors, Louis
  • Papadopoulos, Kyriakos
  • Penas-Prado, Marta
  • Simes, John
  • Walbert, Tobias
  • Scott, Andrew
  • Gomez, Erica
  • Lee, Ho-Jin
  • Roberts-Rapp, Lisa
  • Xiong, Hao
  • Bain, Earle
  • Holen, Kyle
  • Maag, David
  • Reardon, David

publication date

  • 2016